Anti-Ageing Peptides: What Does the Evidence Actually Say?

The Anti-Ageing Promise

Few topics generate more excitement — or more hype — than anti-ageing peptides. The promise of a compound that can slow, stop, or even reverse biological ageing is deeply compelling. But the gap between marketing claims and scientific evidence in this space is often vast.

Let's assess the major anti-ageing peptide candidates honestly.

[GHK-Cu](/peptides/ghk-cu): The Strongest Case

Of all the peptides positioned for anti-ageing, GHK-Cu has arguably the most substantive evidence base.

What's well-established: - GHK-Cu levels decline significantly with age (from ~200ng/mL to ~80ng/mL) - Topical GHK-Cu improves skin thickness, elasticity, and collagen production in clinical studies - GHK-Cu modulates gene expression in the direction of "younger" tissue patterns - Wound healing acceleration and scar reduction are well-documented

What's speculative: - Whether systemic GHK-Cu supplementation (injection) provides benefits beyond topical skin effects - Whether gene expression changes translate to meaningful lifespan or healthspan improvements - Whether GHK-Cu can reverse deep tissue ageing (organ function, cardiovascular ageing)

Honest assessment: GHK-Cu is a legitimate anti-ageing compound for skin specifically. For systemic anti-ageing, the evidence is suggestive but incomplete. It's one of the better-supported candidates, but calling it a proven anti-ageing treatment overstates the evidence.

[Epithalon](/peptides/epithalon): Intriguing Theory, Limited Proof

Epithalon's anti-ageing case rests on telomerase activation and animal longevity data.

What's established: - Epithalon activates telomerase in cell culture - Some animal studies show modest lifespan extension - Melatonin production normalisation in aged animals

What's missing: - Independent replication of key findings - Human clinical data - Long-term safety data (especially regarding cancer risk from telomerase activation)

Honest assessment: The biological mechanism is plausible. The supporting evidence comes predominantly from one research group. No human anti-ageing data exists. It's a genuinely interesting research compound, but current evidence doesn't support strong anti-ageing claims.

GH Secretagogues: Complex Relationship with Ageing

Growth hormone declines with age, and GH secretagogues (Ipamorelin, Hexarelin, CJC-1295, MK-677) restore more youthful GH levels. This forms the basis of the anti-ageing argument.

What's established: - GH levels decline with age (somatopause) - GH secretagogues effectively increase GH and IGF-1 levels - Short-term benefits include improved body composition (reduced fat, increased lean mass), better sleep quality, and improved skin

The complication: - The insulin/IGF-1 signalling pathway is actually associated with shorter lifespan across multiple species. Organisms with reduced GH/IGF-1 signalling often live longer. - GH replacement studies in elderly humans show mixed results — improvements in body composition but increases in adverse events - The relationship between GH levels and healthy ageing is not linear

Honest assessment: GH secretagogues may improve certain age-related symptoms (body composition, sleep, skin) in the short term. Whether they extend lifespan or healthspan is unknown and the theoretical argument is actually conflicted. Using them purely for "anti-ageing" is a bet without clear evidence of the payoff.

BPC-157: Indirect Anti-Ageing Potential

BPC-157 isn't typically classified as an anti-ageing peptide, but its tissue-protective properties are relevant to ageing.

The connection: Much of ageing is accumulated tissue damage that wasn't fully repaired. A compound that accelerates and improves tissue repair could theoretically slow the accumulation of age-related damage.

What's established: - BPC-157 accelerates repair of multiple tissue types - It has neuroprotective properties - Gastric protective effects may help maintain gut health with age

Honest assessment: BPC-157 addresses consequences of ageing (tissue damage, reduced healing capacity) rather than ageing mechanisms themselves. It's a maintenance tool, not a reversal agent.

What "Anti-Ageing" Actually Means

The term "anti-ageing" encompasses very different things:

1. Lifespan extension — living longer. No peptide has demonstrated this in humans. 2. Healthspan extension — staying healthy longer. Some peptides may contribute to this by maintaining tissue function. 3. Cosmetic anti-ageing — looking younger. GHK-Cu has genuine evidence here. 4. Biomarker improvement — improving age-related markers (GH levels, telomere length, etc.). Several peptides can do this, but whether biomarker improvement translates to meaningful outcomes is the critical unanswered question.

The Responsible Perspective

The most honest statement about anti-ageing peptides in 2027 is this: several peptides have biological mechanisms relevant to ageing processes, and some have supporting preclinical or limited clinical data. None has been proven to extend human lifespan or meaningfully extend healthspan in controlled human trials.

This doesn't mean they're worthless — it means the evidence isn't there yet. Researchers exploring these compounds should do so with appropriate expectations and rigorous methodology, not with the certainty that marketing materials suggest.

For individual peptide profiles, visit our Peptide Library.